HeartBeam (NASDAQ: BEAT), a medical-technology company developing advanced electrocardiogram solutions, was featured in ...
Experts say the emerging tech can dramatically accelerate advances in drug discovery, diagnostics and precision medicine.
Patients with pulmonary adenocarcinoma consulted the neurology department due to multiple initial symptoms of cerebral ischaemia. Examination of each patient revealed pulmonary embolism, the ...
Explore how late-night shifts impact health and genetics, and discover strategies to reclaim your well-being for future ...
Parents with early-onset heart disease face unique struggles in their own recovery and childcare, indicating the need for ...
Northwell Health reports that women's heart health requires unique attention due to historical male bias in research ...
A recent cross-sectional study found that dobutamine stress echocardiography (DSE) provides high specificity (97.4%) for ...
Artificial intelligence (AI) has become an indispensable tool in Estonian hospitals, aiding both stroke and radiation therapy treatment while saving doctors hours of valuable time. At the same time, ...
This review examines how zinc regulates inflammatory and redox signaling pathways involved in myocarditis and pericarditis, ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Air pollution is responsible for at least a third of some of Ghana’s deadliest diseases, including stroke, lung cancer and neonatal deaths, according to the ...
Deep generative perfusion-deficit mapping of CTA-derived computed perfusion maps in 1,393 patients reveals the neural substrates of clinical deficits in the hyperacute phase of ischaemic stroke.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results